PD-L1 IHC testing: issues with interchangeability evidence based on laboratory-developed assays of unknown analytical performance

Gastric Cancer. 2022 Nov;25(6):1131-1132. doi: 10.1007/s10120-022-01336-3. Epub 2022 Sep 26.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • B7-H1 Antigen
  • Humans
  • Immunohistochemistry
  • Immunotherapy
  • Lung Neoplasms*
  • Stomach Neoplasms*

Substances

  • B7-H1 Antigen